Based on the cost–effectiveness threshold of £30,000 or $40,000 per QALY, antiviral therapies can be recommended for influenza treatment and post-exposure prevention in high-risk patients ...
People infected by one influenza virus develop a specific immune response against the HN strain that is unable to recognize the new viral strain. Antiviral drugs can be used to treat influenza ...